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Abstract
In this paper, an overview of advanced robotic surgical systems in ophthalmology is 
provided. The systems are introduced as representative examples of the degree of 
human vs. robotic control during surgical procedures. Details are presented on each 
system and the latest advancements of each are described. Future potential 
applications for surgical robotics in ophthalmology are discussed in detail, with 
representative examples provided alongside recent progress. 
1. Introduction
The integration of robotic surgical systems into operating rooms has become 
common across numerous surgical fields due to their increased precision, higher 
maneuverability, and improved visualization over manually performed surgical 
procedures. In the past two decades, the da Vinci Surgical System (Intuitive 
Surgical, Inc.) has become the most prevalent robotic surgical system with an 
installed base of over 4,000 units worldwide [ref1]. This market share has been used
to perform more than 1.5 million surgical procedures in the fields of gynecology, 
urology, and general surgery [ref1]. The da Vinci Surgical System is a commercially 
available surgical robotic system with FDA approval, but their initial intellectual 
property patents soon expire and competing systems such as Telelap Alf-X and 
Revo-I are undergoing clinical testing and getting closer to entering the market 
[ref2]. Despite this rapid progress, the implementation of surgical robotic systems 
into eye surgery has trailed behind their adoption into other surgical areas. 
The delayed transition of intraocular surgical robotic systems from laboratory 
research prototypes to routine clinical practice can be attributed to the unique 
advantages of intraocular surgery, which may lessen the beneficial impacts of a 
robotic system over the traditional role of a human surgeon. For example, compared
to other surgical fields such as laparoscopy, intraocular surgery benefits from 
relatively unobstructed, high-magnification views of the surgical field. In addition, 
the minimally invasive nature of intraocular instrumentation and the high 
maneuverability and range of manually controlled surgical instruments present 
advantages to the eye surgeon. 
Despite these advantages, intraocular microsurgery remains technically challenging 
to perform. Physical manipulation of tissue must be accomplished with exceptionally
high accuracy and precision in a tiny workspace. The scale of these manipulations is 
so small that intrinsic physiological hand tremor becomes a substantial concern. In 
result, the ability to accurately target a specific anatomical site or hold the surgical 
instrument stationary for prolonged durations is difficult. Also, humans have limited 
resolution when it comes to depth perception [ref3]. This limited resolution is 
insufficient to sense the exact depth of the posterior capsule during cataract surgery
or accurately sense the distance between the tool and retinal anatomy during 
vitreoretinal surgery. For these reasons, robotic systems offer a promising solution 
to these human limitations due to their enabling of precise, tremor-free motion and 
offer increased depth resolution through a variety of integrated imaging modalities 
such as digital microscopy and optical coherence tomography (OCT). These 
advantages naturally increase both the safety and efficacy of surgical procedures. 
By improving resolution and accuracy of depth-sensing capabilities, such unified 
systems promise to supersede the current practice of relying on human vision 
through an optical stereo microscope. Additional benefits of robotic surgery in 
ophthalmology include collaborative capabilities for specific procedures (partially to 
fully automated) and the integration of augmented visual, auditory, and tactile 
feedback. 
 
2. Types of Robotic Surgical Systems
Figure 1: Shown is a categorization that encapsulates major types of human and
robotic surgical
systems.
One method to categorize the range of intraocular robotic surgical systems is 
according to the degree of human vs. robotic control (Figure 1). 
(a) In traditional surgery, a human surgeon controls the surgical tool(s) and uses 
an optical microscope as visual feedback. 
(b) In a robot-assisted tool, the surgical tool itself is modified to be a miniature 
robotic system (Figure 2). The surgeon controls this tool to perform a hands-
on surgical procedure while the robotic tool offers tremor cancellation, depth 
locking, and other features. An example of this type is the MICRON (Section 
3.1). 
(c) In teleoperated robotic surgery, the surgeon controls a robotic system 
through joysticks and uses an optical microscope or digital heads-up display 
as visual feedback. The joystick motion is directly mapped to robotic motion 
and therefore advantages such as haptic feedback, tremor filtering, and 
motion scaling can be implemented. Examples of this type include RAM!S 
(Section 3.2), the Preceyes Surgical System (Section 3.3), and the IRISS 
(Section 3.5). 
(d) In a cooperative robotic system, the surgeon holds and controls the surgical 
tool simultaneously with the robotic system and uses a microscope and/or 
OCT as visual feedback. The surgeon maintains direct manual control over the
motion of the surgical tool while the robotic system provides assistive 
compensation for hand tremor and allows for prolonged immobilization of the 
surgical tool. An example of this type is the system from the Catholic 
University of Leuven (Section 3.4). 
(e) Finally, in a partially or fully automated system, the robotic system is tightly 
integrated with the microscope and/or OCT to provide feedback and guidance 
to the motion commands of the robotic system, which directly holds and 
operates the surgical tool(s). Specific procedures or steps of a procedure are 
automatically performed by the robotic system while the surgeon supervises 
through the provided visual feedback. Override commands are commonly 
offered. An example of this type is the IRISS (Section 3.5). 
The following section presents the latest, most advanced intraocular robotic systems
for each of the types outlined above. 
3. Advanced Surgical Robotic Systems 
3.1 The MICRON
The MICRON, an active hand-held micro-manipulator was developed in 2010 through
a collaboration between the Robotics Institute at Carnegie Mellon University and 
Johns Hopkins University [ref4]. Through an image-guidance approach, the handheld
device reduced hand tremor to provide smooth motion during surgical procedures 
with a reported 52% reduction in tool-tip positional error. The tool was evaluated by 
performing retinal vein cannulation on ex vivo pig eyes and demonstrated an 
increase in success rate from 29% to 63% over the case of not using the augmented
tool. 
Figure 2: The MICRON hand-held robotic manipulator [ref5]
The MICRON was further improved in 2015 though incorporation of a Gough-Stewart 
platform that constrained the remote center of motion near the tool tip [ref5]. The 
improved tool was evaluated under varying conditions to demonstrate trajectory-
following errors of ≤ 20 µm and a 90% reduction in hand tremor. Most recently, the 
researchers demonstrated the ability to detect the puncture of a stretched vinyl 
membrane by integrating a force-sensing needle into the MICRON [ref6]. In addition,
the group also demonstrated an automated position-holding feature that allowed the
tool tip to be maintained inside an artificial vein for longer periods of time with 
significantly reduced tool-tip motion after venipuncture. However, to date, all 
evaluation studies have only been performed on artificial or animal eye models with 
no clinical evaluation.
3.2 RAM!S 
In 2013, the Department of Robotics and Embedded Systems at the Technical 
University of Munich introduced RAM!S (Figure 3), a hybrid parallel–serial 
mechanism that includes piezoelectric motors for actuation [ref7]. Kinematically, the
mechanism consists of two joints coupled in parallel, one prismatic joint, and one 
optional revolute joint to collectively enable 6 DOF of tool motion [ref8]. The 
researchers claim the advantages of this mechanism include higher stiffness and 
increased precision over more common serial mechanism designs. RAM!S is also 
physically compact (94±28 × 33.5 × 18.5 mm) and designed to secure to the head 
of a patient to mitigate the effects of patient motion. Additional cited metrics include
a tool-tip positional precision of 5 µm, a total weight of 306 g, and a tool-tip 
workspace of 28 × 28 × 28 mm. 
Figure 3: The RAM!S system from the Technical University of Munich [ref7].
The same team developed a virtual-fixture control method and experimentally 
evaluated its use on an ex vivo pig eye [ref9]. These virtual fixtures included the 
virtual constraint of the RCM and autonomous RCM adjustment. Additional work 
used the RAM!S device to develop teleoperated capabilities [ref10]. Using a 
controller that featured force feedback, a control scheme for the positional error was
implemented. The resulting system allowed the surgeon to perform precise and 
comfortable micromanipulation. More recently, sub-retinal depth-tracking of a 
needle using OCT has been performed [ref11]. 
In the researcher’s latest work, the performance of the device’s software-
constrained RCM was evaluated through a series of experiments using a tissue 
model and ex vivo pig eyes [ref12]. The RCM was demonstrated to operate with an 
accuracy of within 1 mm. Furthermore, the researchers used the system to track the
depth of the needle during insertion into models, supplementing the microscopic 
imagery by also displaying OCT-generated volume scans of the needle. The 
researchers claimed that with the help of their system, surgeons could focus more 
on making decisions during sub-retinal injection and less on dexterous control of the
tool. 
3.3 The Preceyes Surgical System
The Eindhoven University of Technology in the Netherlands and later Preceyes B.V., 
a spin-off company of the university, has developed the Preceyes Surgical System 
(Figure 4) as a high-precision device for vitreoretinal surgical procedures [ref13]. 
The robotic system is comprised of an input joystick held by the surgeon and a 
robotic system which controls the surgical instrument and performs the physical 
manipulation of intraocular tissue. The robotic system is rigidly secured to the 
operating room table or Stryker by a headrest and aligned to the surgical incision by
the surgeon. By moving the input joystick, the surgeon can guide the motion of the 
tool through the incision and throughout the intraocular workspace. The surgeon 
uses a standard surgical microscope as visual feedback and the robotic system is 
compact enough to unobtrusively fit within the operating room environment.
Figure 4: The Preceyes Surgical System developed by Preceyes B.V. [ref13]
The design of the robotic system is based on a parallelogram linkage common to 
many early surgical robotic systems. This design offers a mechanical remote center 
of motion and improved tool-tip positional precision over serial linkages. The 
system’s safety and stability are enhanced by an adjustable counterweight which 
minimizes the required joint torques and holds the system in a fixed configuration in
the event of a power loss or system failure. The authors reported a tool-tip positional
resolution of 10 µm and initially demonstrated the capabilities of Preceyes by 
creating venous occlusions in live, anesthetised pigs [ref13]. The use of the robot to 
assist in surgical procedures was considered amenable to the standard surgical 
workflow and allowed the surgeon to sit in his or her usual position.
In 2018, the Preceyes Surgical System was used to conduct a clinical trial to 
compare robot-assisted surgery with traditionally performed surgery [ref14]. In this 
study, two sets of trials were performed in patients requiring the removal of retinal 
membranes and in patients that required sub-retinal injection. In the first stage, the 
Preceyes system was used to lift a flap of a retinal membrane from the macula 
surface using a beveled needle. Twelve patients with macular holes were recruited 
for this study and the patients underwent general anesthesia maintained with 
muscle relaxation and mechanical ventilation to ensure elimination of spontaneous 
respiration. The tool-tip directional motion perpendicular to the retina was 
constrained to increments of 10 µm. Once positioned, the surgeon imposed a virtual 
boundary in the control software such that any additional depth commands would 
be prohibited and iatrogenic retinal trauma could be prevented. Although the robot-
assisted surgeon required more time than the unassisted surgeon to perform the 
surgical procedures (295 s compared to 80 s), the degree of iatrogenic retinal 
trauma during robot-assisted surgeries (defined as retinal touches and micro-
hemorrhages) was decreased. 
In the second stage, the Preceyes was used to perform sub-retinal injection of 
recombinant tissue plasminogen activator (rtPA) in three patients with central vision
loss due to sub-retinal hemorrhage. In this study, three patients were placed under 
local anesthesia and the robot assisted in the delivery of 0.025–0.10 ml of rtPA into 
the sub-retinal space. In one patient, transient intraoperative exacerbation of 
cataract precluded a clear view of the cannula tip and was manually completed, but 
otherwise the sub-retinal injections were successfully performed in all three 
patients. 
Indicative of the safety of the robotic system, the robot-assisted procedures resulted
in fewer overall inadvertent retinal touches and micro-hemorrhages across all trials. 
No system malfunctions or technical glitches were encountered and the robotic 
system was deemed by the surgeon to be unobtrusive within the operating theater. 
While the robot-assisted surgeon performed slower than unassisted surgeon, the 
decrease in surgical complications and the increased precision of the robotic system
suggests a bright future for the incorporation of surgical robotics into the field of 
intraocular eye surgery. The Preceyes recently acquired CE mark status and is 
expected to continue undergoing clinical evaluation by Preceyes B.V. 
3.4 Catholic University of Leuven System 
In 2014, the Micro- and Precision Engineering Group at the Catholic University of 
Leuven presented a teleoperated robotic system (Figure 5) complete with motion 
scaling, tremor compensation, and scaled force feedback [ref15]. This system is a 
co-manipulated robotic system designed to offer a surgeon increased stability and 
precision by reducing the magnitude of hand-generated tremor and facilitating the 
ability to maintain a fixed position for prolonged durations. The device consists of a 
parallel arm mechanism with a mechanical remote center of motion and is 
controlled through a spherical mechanism. This system was used to perform retinal 
vein cannulation on in vivo pig eyes [ref16]. Complete success was defined as a 
stable intravenous position of the needle tip for more than three minutes, and was 
confirmed in 15 out of 18 eyes. No technical failures of the robotic device were 
reported. 
Figure 5: The intraocular robotic system of the Catholic University of Leuven,
Belgium [ref17].
Following this initial success, the same group reported on the clinical evaluation of 
their system in the world’s first, in-human, robot-assisted retinal vein cannulation 
[ref17]. In this study, four patients with retinal vein occlusion were treated at the 
University Hospital of Leuven through a phase I clinical trial. The trial involved the 
injection of Ocriplasmin into targeted retinal veins (estimated diameters 100–150 
µm) with injection durations of up to 10 minutes. The successful results 
demonstrated the technical feasibility of performing retinal vein cannulation with the
aid of robotic technology using a stereo microscope and suitable intraocular 
illumination. The robotic system is now being developed by MYNUTIA, a spin-off 
company of the university and the project leads are working to commercialize the 
developed technology. 
3.5 The Intraocular Robotic Interventional Surgical System (IRISS)
The Intraocular Robotic Interventional Surgical System (IRISS) was developed at the 
University of California, Los Angeles through collaboration between the Mechatronics
and Control Laboratory and the Stein Eye Institute (Figure 6). The overall goal of 
this work is to develop a robotic surgical system capable of performing anterior and 
posterior intraocular surgical procedures through combinations of augmented-reality
teleoperation and full automation. 
Figure 6: The Intraocular Robotic Interventional Surgical System (IRISS).
First presented in 2013 [ref18], the IRISS was aimed at remotely performing a wide 
range of anterior and posterior segment surgical procedures. The robotic system 
features a quick tool-exchange mechanism capable of mounting any commercially 
available surgical instrument and switching between them outside of the eye in a 
matter of milliseconds. In addition, a novel aspect of this robotic system is its dual-
arm configuration which enables two tools to be simultaneously used within the eye 
through two surgical incisions in close proximity about the mechanically determined 
remote center of motion [ref19]. The surgeon teleoperates the robotic system from 
a distance through a pair of custom joysticks that are mapped to the robot motion 
with a collection of motion-scaling and tremor-reduction techniques. These features 
help increase the safety and improve the performance of the surgeon. The system 
enables three-dimensional visual feedback through a stereo camera integrated into 
the digital microscope and displayed to the surgeon via a heads-up monitor. 
The IRISS was validated on a set of common cataract and vitreoretinal surgical 
procedures using ex vivo pig eyes in a standard operating theater [ref20]. Using the 
IRISS, the surgeon was able to successfully perform teleoperated anterior lens 
capsulorhexis, viscoelastic injection, hydro-dissection, lens aspiration, retinal vein 
cannulation, and vitrectomy [ref18, ref20]. In particular, retinal vein cannulation was
performed to demonstrate the ability of the IRISS to perform accurate targeting 
tasks. In many of the procedures, the second arm was used to control an additional 
tool and demonstrate the unique ability of the IRISS to simultaneously operate two 
surgical instruments. Finally, the IRISS was the first robotic system to successfully 
perform a complete a curvilinear capsulorhexis and an entire cataract surgery from 
start to finish. 
However, with the introduction of femtosecond laser systems and other emerging 
technological advances, the completion of specific steps of cataract surgery such as 
corneal incisions, capsulorhexis, and lens fragmentation can be accomplished 
without any manual manipulation of intraocular tissue. While these laser-based 
methods naturally improve safety and decrease surgical complications, they are 
unable to perform the removal of emulsified cortical material or the insertion of an 
intraocular lens implant. These steps must still be manually performed by a surgeon 
and surgical complications remain due to the physiological limitations of a human 
surgeon and deficiencies in sensing capabilities. 
Figure 7: The experimental setup for automated lens extraction on ex vivo pig eyes
using the IRISS. 
To this end, the IRISS was integrated with an OCT system and this feedback used to 
perform automated cataract extraction [ref21]. In this work (Figure 7), ex vivo pig 
eyes were manually prepared by a surgeon and the robotic system modeled the eye
anatomy, planned an extraction trajectory, and autonomously removed the lens 
material from the capsular bag. The system automatically aligns itself to the eye 
and guides an irrigation/aspiration handpiece through the corneal incision. The 
anatomical structures within the anterior segment are then identified and modeled 
from a set of preoperative OCT volume scans using an image-processing algorithm. 
This model is used by the system to plan a tool-tip trajectory through the capsular 
bag optimized for mobilizing lens material and increasing surgical efficacy and 
efficiency while maintaining safety. This trajectory is then tracked by the system 
while controlling irrigation and aspiration forces as a function of tip-to-tissue 
distance. While the lens-extraction step is fully automated, intraoperative 
supervision and manual intervention abilities were provided to the surgeon. 
Intraoperative OCT scans localized around the tool tip are displayed to the surgeon 
in real time. 
In the latest work from the IRISS group, the OCT-integrated robotic system was 
evaluated in a clinical setting on ex vivo pig eyes [ref22]. The automated procedure 
was performed on 30 eyes and preoperative, intraoperative, and postoperative OCT 
volume scans were acquired for analysis. In addition, microscope-based examination
was performed by a trained surgeon to assess the integrity of the tissues and to 
determine if lens material remained. Results indicated that posterior capsule rupture
was avoided in all 30 trials. Complete lens extraction was achieved on 25 of the 
samples—in five of the samples, minute particles of lens material were discovered in
the postoperative evaluation hidden behind the iris where the OCT was unable to 
image. 
Figure 8. Surgical cockpit enabled with augmented reality for robot-assisted,
vitreoretinal surgery located in the Advanced Robotic Eye Surgery Lab at the
University of California, Los Angeles.
Future work on the IRISS includes the integration of augmented reality and 
integration of specific, automated procedures into the surgical experience. We 
envision a surgical system with an augmented-reality cockpit integrated with multi-
sensory feedback including image overlays on microscope and OCT feedback 
displays, auditory, and haptic feedback. We have recently performed studies in the 
virtual environment (Figure 8) to demonstrate that the addition of this feedback 
improves surgeon performance during pre-retinal membrane peeling procedures 
[ref23]. Participants over a range of skillsets were asked to perform virtual pre-
retinal membrane peeling using two sets of feedback: (1) vision only and (2) vision 
with haptic feedback. Results demonstrated a reduction in task-completion time and
retinal damage when the visual display was fully augmented. 
4. Future Applications for Surgical Robotics in Ophthalmology 
The  incorporation  of  robotic  systems  into  ophthalmological  surgical  practice
promises improved precision and the possibility of entirely new surgical procedures
that  are  currently  infeasible  or  impossible  to  perform.  Laser-based  surgical
procedures  (such  as  femtosecond  laser-assisted  cataract  surgery)  have  already
provided super-human levels of  accuracy  and safety to lower intraoperative and
postoperative complication rates.  In addition, microscope-integrated OCT (MIOCT)
have enabled improved visualization and introduced the ability to accurately sense
depth during surgical procedures through incorporation of a real-time OCT image
feed  displayed  alongside  the  microscope  view.  Despite  these  technological
advances, surgical complications remain because manipulation of intraocular tissue
remains  dependent  on  human  surgical  skills,  susceptible  to  hand  tremor  and
subjected to limited resolution of depth perception. 
For  cataract  surgery,  robotic  manipulators  can  be  integrated  with  existing
femtosecond  laser  systems  to  perform  complete  cataract  extraction.  Although
cataract  surgery  is  common and its  complication  rate  is  low compared to  other
intraocular  surgeries,  posterior  capsule opacification (PCO) has been detected in
67%  of  surgical  cases  in  a  four-year  follow-up  study  [ref24].  PCO  results  from
incomplete removal of lens from the capsular bag, caused by inadequate sensing
and  visualization  of  the  lens  remnants—making  complete  removal  difficult.
Therefore, a future application of a robotic system is in the reduction of PCO through
improved sensing of the lens equator and complete lens material cleaning in both
pupillary and equatorial areas via capsular polishing techniques. 
Sensing deficiencies also increase the risk of posterior capsule rupture, which is the
most  common  complication  that  occurs  during  nucleus  emulsification,  cortex
removal,  and capsule polishing [ref25].  The capsular bag (including the posterior
capsule) is an imperceptible and delicate tissue with thickness of approximately 10
µm  [ref26].  Posterior  capsule  rupture  may  occur  with  inappropriate  levels  of
aspiration  or  inaccurate  maneuvers  of  the  phacoemulsification  or
irrigation/aspiration tool when in close proximity to the capsule. By combining high-
resolution  intraocular  OCT  imaging  and  high-accuracy  robot  manipulations,
localization of the posterior capsule in its entirety, from the posterior pole to the lens
equator could be used to safely guide the surgical instrument for cataract extraction
and subsequently reduce the risk of posterior capsule rupture. Furthermore, OCT
feedback and accurate intraocular  manipulation also enables precise OCT-guided
intraocular lens implantation. 
A potential future application of intraocular robotic systems includes gene and stem-
cell  therapy which are  currently  experiencing remarkable  momentum for  severe
retinal disorders [ref27, ref28]. To be effective, these procedures require accurate
and prolonged injection in the vitreous or into the subretinal space where traditional
intravitreal  drug-delivery  techniques  are  not  ideal.  Several  studies  on  subretinal
applications  have  been  performed  without  robotic  assistance  and  have
demonstrated promising results in treating diseases such as age-related macular
degeneration,  Stargardt’s  disease,  and  choroideremia  [ref29-ref32].  However,
compared to traditional intravitreal drug-delivery techniques, subretinal injection is
associated with an increase in surgical complications such as vitreous hemorrhage,
retinal detachment, and postoperative development of choroidal neovascularization
[ref33,  ref34].  For  these  reasons,  the  method  of  drug  delivery  must  be  further
studied to provide a safe and effective treatment option. A surgical robotic system is
expected to possess the precision and accuracy critical for proper drug delivery and
therefore may supersede human performance with hand-held tools.
Another potential future application of intraocular surgical robotic systems might 
involve the treatment of retinal vein occlusion (RVO). RVO is a hardening of a retinal
vein and the formation of a blood clot that can cause vision loss through macular 
edema, glaucoma, or vitreous hemorrhage and affects approximately 2% of the 
population [ref35]. One potential cure is retinal vein cannulation. In this technique, 
the clogged vein is cannulated by a micropipette and an anticoagulant is injected 
into the lumen to dissolve the clot. The anticoagulant must be continuously injected 
over a prolonged duration and therefore the surgical tool must be held steady inside
the vein. However, retinal vein diameters are approximately 120–200 µm 
[ref36,ref37] while human hand tremor has been measured as 200–350 µm [ref38]. 
Therefore, the motion stability and accurate positioning requirements results in a 
procedure that would be exceptionally difficult for a human surgeon to successfully 
perform, but not for a robotic system. To date, successful robot-assisted vein 
cannulation has been demonstrated in both animal models [ref13, ref39, ref20] and 
human patients [ref17] but has not yet received widespread validation as a safe and
efficient therapeutical option. 
In the immediate future, the direction of intraocular robotic systems is towards 
improved visualization and robotic-assistance of specific and routine tasks. 
Conceivably, these tasks could be fully or partially automated and independently 
performed from a human operator or surgeon. These achievements could only be 
accomplished through improved feedback from OCT or another image modality that 
is tightly integrated and accurately registered with the robotic system.  Similarly, we
envision surgical systems with immersive, augmented-reality cockpits complete with
multi-sensory feedback. Such integrated augmented-reality visual displays could 
improve the safety and efficacy of performing complete intraocular procedures. This 
might be especially beneficial in complex retinal surgical cases such as dissecting 
severe preretinal tissue where accurate, bimanual manipulation is necessary but 
limited by current sensing capabilities and the difficulty of bimanual operation. In 
the distant future, it is conceivable that intraocular robotic systems guided by 
artificial intelligence could even possess the ability to make surgical decisions 
without any input from a human surgeon.
5. Conclusion
The full potential of robotics in intraocular surgical applications lies in the 
development of sight-improving or sight-saving procedures that are currently 
impossible for a human surgeon to perform. Prolonged cannulation of retinal vessels
or accurate delivery of stem cells or gene-therapy drugs into sub-retinal spaces are 
applications that fall into this area, but there may be other applications, currently 
unimagined, waiting to be discovered. It has been widely demonstrated that 
improved tool precision can reduce anatomical damage and improve surgical 
outcomes in a clinical setting, and the ability to enable completely new surgical 
techniques uncommon in current practice is not unrealistic. Despite the potential, 
improvements to existing systems and their acceptance into general practice is 
required before intraocular surgical robotic systems can be commonly deployed into
operating rooms or in the offices of practitioners.
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